Global Blood Culture Tests Market is expected to reach USD
6.6 billion by the year 2025, according to a new report by Grand View
Research, Inc. The increasing prevalence of bloodstream infections and
infectious diseases is the most significant factor anticipated to propel the
market growth during the forecast period. Increasing demand for advanced
diagnostic techniques for the diagnosis of infectious diseases, such as sepsis,
is the main factor that drives growth of the market. Thus, many manufacturing
companies have begun focusing on development of advanced diagnostic instruments
and consumables.
The introduction of various government initiatives
pertaining to the prevention and control of infections is likely to propel the
demand for blood culture tests. According to CDC, there was 46% decrease in
central line-associated bloodstream infections between 2008 and 2013 in the
U.S., owing to efforts taken by the U.S. government for the prevention of
hospital-acquired infections.
Full Research Report on Global Blood Culture Test Market
Analysis:
http://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market
http://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market
Further key findings from the report suggest:
- Conventional
blood culture technique is the largest revenue-grossing segment owing to
huge applications of this method in hospitals, independent clinical
laboratories, and pathology laboratories
- In
the product segment, consumables accounted for the largest revenue share
in 2016, due their huge applications in diagnostics & research, with
repetitive purchase of these consumables, such as blood culture media,
assay, kits, and reagents, adding to the revenue
- Automated
blood culture systems segment is the fastest growing segment of the blood
culture tests market owing to the advantages of automation, such as low
chances of error, faster result generation, etc.
- Molecular
technology segment is projected to grow at the highest CAGR, because of
increasing demand for advanced products by hospitals and laboratories for
diagnosis of infectious diseases
- Bacterial
infections accounted for the largest revenue share in 2016, due to the
fact that they are the most common cause for infection in the blood
- Reference
laboratories is projected to grow at the highest rate during the study
period, because there is an increase in outsourcing of blood tests by
hospitals to reference laboratories
- North
America is the leading regional sector that accounted for the largest
revenue share of the blood culture tests market in 2016, because of the
presence of well-developed healthcare infrastructure in this region
- The
Asia Pacific region is anticipated to grow at the highest CAGR during the
forecast period owing to increased focus of government on the prevention
of infectious diseases
- Some
of the major players are Becton, Dickinson and Company; bioMérieux SA;
Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation;
Roche Diagnostics; Bruker Corporation; Abbott Laboratories; and Alere
View more reports of
this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research
has segmented the Global Blood Culture Tests Market on the basis of product,
technique, technology, application, end-use, and region:
Blood Culture Tests Product Outlook (Revenue, USD
Million; 2014 - 2025)
· Consumables
· Blood
culture media
§ Aerobic
blood culture media
§ Anaerobic
blood culture media
§ Fungi/yeast
blood culture media
§ Others
blood culture media
·
Assay, kits, and reagents
·
Blood culture accessories
·
Instruments
·
Laboratory equipment
§ Incubators
§ Colony
counters
§ Microscopes
§ Gram
stainers
·
Automated blood culture systems
·
Software & services
Blood Culture Tests Technique Outlook (Revenue, USD
Million; 2014 - 2025)
- Conventional
blood culture technique
- Automated
blood culture technique
Blood Culture Tests Technology Outlook (Revenue, USD
Million; 2014 - 2025)
- Culture-based
technology
- Molecular
technology
- PCR
- Microarray
- PNA-FISH
- Proteomic
technology
Blood Culture Tests Application Outlook (Revenue, USD
Million; 2014 - 2025)
- Bacterial
infections
- Fungal
infections
- Mycobacterial
infections
Blood Culture Tests End-use Outlook (Revenue, USD
Million; 2014 - 2025)
- Hospitals
laboratories
- Reference
laboratories
- Others
Blood Culture Tests Regional Outlook (Revenue, USD
Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
View Press Release of this research report by Grand View
Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment